跳至主要内容
临床试验/ISRCTN77442023
ISRCTN77442023已完成未知

Investigation of the effect of glucagon-like-peptide-1 (GLP-1) on left ventricular function during elective coronary angioplasty and stenting

Papworth Hospital NHS Foundation Trust (UK)0 个研究点目标入组 40 人开始时间: 2010年4月23日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age over 18 (male or female and no upper age limit)
  • 2. Able to give informed consent
  • 3. On the waiting list for elective PCI to a single vessel coronary stenosis
  • 4. Normal left ventricular function

排除标准

  • 1. Atrial fibrillation
  • 2. Myocardial infarction less than 3 months previously
  • 3. Previous coronary artery bypass grafts
  • 4. Treatment with insulin, sitagliptin, vildagliptin or exenatide

研究者

发起方
Papworth Hospital NHS Foundation Trust (UK)

相似试验

进行中(未招募)
1 期
iraglutide to Short Bowel Syndrome, a cross-over studyShort bowel syndrome (SBS) is a clinical situation with reduced absorptive mucosal surface due to extensive surgical resection. SBS leads to increased intestinal losses of fluids and electrolytesrestricted oral/enteral nutrition to reduce intestinal lossesdisease-related hypophagialack of adaptive hyperphagiaaccelerated gastrointestinal transit timeMedDRA version: 19.1Level: PTClassification code 10049416Term: Short-bowel syndromeSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2015-000825-35-DKRigshospitalet Blegdamsvej16
已完成
1 期
The effect of the glucagon-like peptide-1 analogue, exenatide, on duodenal motility and flow events, and small intestinal transit in healthy humans and type 2 diabetes mellitus.
ACTRN12608000428369Royal Adelaide Hospital24
尚未招募
不适用
Investigating the role of the glucagon-like peptide 1 system on foodcue-induced brain activation – a non-interventional longitudinalfunctional magnetic resonance imaging studyE66.9Obesity, unspecified
DRKS00033360Zentralinstitut für Seelische Gesundheit, Klinik für Abhängiges Verhalten und Suchtmedizin, repräsentiert durch60
已完成
2 期
Effects of Glucagon-Like Peptide-1 (GLP-1) administration on gastric emptying during periods of hyperglycaemia in healthy volunteers.Glycaemic control and gastric emptyingMetabolic and Endocrine - Other metabolic disorders
ACTRN12613001384741Dr Mark Plummer15
招募中
2 期
The Effect of Prolonged Glucagon-like Peptide 1 Infusion on Gastric Emptying in Healthy VolunteersHyperglycaemiaCritical Illness Induced HyperglycaemiaMetabolic and Endocrine - DiabetesDiabetes
ACTRN12612001035819Mahesh Umapathysivam10